Literature DB >> 12435147

Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice.

Lori D Campbell1, Julie N Stewart, Jan R Mead.   

Abstract

To determine the role of cytokines and a chemokine receptor in the susceptibility to, and outcome of, infection, 4 different knockout mice (IL-4, IL-10, IL-12, and CCR5) were infected with Cryptosporidium parvum and monitored for infection intensity by collection of fecal pellets from individual mice. Because adult immunocompetent mice are refractory to infection, wild-type mice on the same background as the knockout mice (C57BL/6) were used as a negative control. No infection was detected over a 4-wk time period in IL-4, IL-10, and CCR5 knockout mice inoculated with 106 oocysts. IL-12 knockout mice inoculated with as little as 100 oocysts shed up to 10,000 oocysts/100 microl of feces on the peak infection day (day 8) and were able to fully recover by 2 wk after infection. IL-12 is an important inducer of IFN-gamma, which probably accounted for susceptibility to infection. Previous studies using IFN-gamma knockout mice have shown strain-related differences in infection intensity and outcome, with increased parasite loads and decreased survival among IFN-gamma knockout mice on a C57BL/6 background compared with those on a BALB/c background. Similar results were observed in IL-12 knockout mice on a BALB/c background, which exhibited little or no infection, despite higher levels of inoculation (10(6) oocysts/mouse).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435147     DOI: 10.1645/0022-3395(2002)088[1014:STCPII]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  15 in total

1.  CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice.

Authors:  Daniel S Korbel; Farah M Barakat; James P Di Santo; Vincent McDonald
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

2.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases.

Authors:  Fengguang Guo; Haili Zhang; Nina N McNair; Jan R Mead; Guan Zhu
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

4.  Enrichment of Cryptosporidium parvum from in vitro culture as measured by total RNA and subsequent sequence analysis.

Authors:  Jessica C Kissinger; Karen E Hermetz; Keith M Woods; Steve J Upton
Journal:  Mol Biochem Parasitol       Date:  2017-12-29       Impact factor: 1.759

5.  Prodrug activation by Cryptosporidium thymidine kinase.

Authors:  Xin E Sun; Lisa Sharling; Mani Muthalagi; Devaraja G Mudeppa; Krzysztof W Pankiewicz; Krzysztof Felczak; Pradipsinh K Rathod; Jan Mead; Boris Striepen; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

6.  Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Authors:  Rihua Xu; Honglin Jia; Mohamad Alaa Terkawi; Xuenan Xuan; Heping Zhang
Journal:  Curr Microbiol       Date:  2011-02-20       Impact factor: 2.188

7.  Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.

Authors:  Corey R Johnson; Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; Xiaoping Liu; Boris Striepen; Jan R Mead; Gregory D Cuny; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

8.  Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.

Authors:  Humphrey N Ehigiator; Pablo Romagnoli; Jeffrey W Priest; W Evan Secor; Jan R Mead
Journal:  Parasitol Res       Date:  2007-05-09       Impact factor: 2.289

Review 9.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

10.  Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.

Authors:  Fengguang Guo; Haili Zhang; Jason M Fritzler; S Dean Rider; Lixin Xiang; Nina N McNair; Jan R Mead; Guan Zhu
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.